Emergent BioSolutions moves forward with typhoid vaccine
Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial.
Archives for October 10, 2007
It's a NanoDrop for Thermo Fisher Scientific
Thermo Fisher Scientific has acquired micro-volume UV-Vis (ultra violet visible) instrument manufacturer NanoDrop Technologies for an undisclosed amount.
Lab-on-a-chip enables cell-free protein synthesis
Researchers have developed a new microfluidic device that enables high-throughput (HT), cell-free protein synthesis for genomic and proteomic functional analysis.
Avecia takes on new MS drug
Avecia Biologics has signed a development and manufacturing deal with US firm BaroFold, making use of the company's protein processing technology to produce its lead interferon-based multiple sclerosis (MS) candidate.
Ablynx decides to go it alone with camel-based mini-antibodies
Ablynx, a biopharma firm that specialises the potentially lucrative sector of miniature antibodies, has announced it plans to launch on the stock market this year.
Wyeth and Zealand seek to still irregular beating heart
Wyeth has begun first-in-man trials for an oral drug designed to calm an irregular heart beat, triggering a milestone payment to its partner on the project, Denmark-based Zealand Pharma.
Kinaxo adds new proteomics service
Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process.